Experiencia en el uso de microrregistro para estimulación cerebral profunda del núcleo subtalámico en pacientes con enfermedad de Parkinson

Autores/as

  • José Libardo Bastidas Benavides Jefe del Servicio de Neurocirugía Funcional, Unidad de Movimientos Anormales Clínica Soma. Medellín, Colombia.
  • Javier Mauricio Serrano Ortiz Neurocirujano, Universidad de Antioquia.
  • Mauricio Rueda Acevedo Neurólogo, Unidad de Movimientos Anormales, Clínica Soma. Medellín, Colombia.
  • José Bareño Silva Magister en Epidemiología, Universidad Centro de Estudios Superiores de Medellín.

DOI:

https://doi.org/10.47924/neurotarget2015210

Palabras clave:

Enfermedad de Parkinson, Estimulación cerebral profunda, Registro con microelectrodos

Resumen

Introducción: El uso de Microregistro (MR) para colocación de electrodos de Estimulación Cerebral Profunda (ECP) continúa siendo debatido en la corrección del blanco preoperatorio, complicaciones y resultados. Describimos la experiencia de su uso en el mapeo del Núcleo Subtalámico (NST) en pacientes con Enfermedad de Parkinson (EP).
Materiales y métodos: Se realizó un estudio observacional, retros- pectivo de pacientes con EP tratados desde 2009 hasta 2012. Se describió la discrepancia entre la planeación inicial y la definitiva a través de la suma de los vectores de desviación en los planos X y Y, complicaciones y porcentaje de mejoría, correlacionado con varia- bles demográficas, anatómicas y de la evolución de la enfermedad.
Resultados: Se trataron 43 pacientes, se implantaron 81 electrodos. La desviación media del blanco preoperatorio fue 2,57 mm. El 71,6% de los electrodos tuvieron desviación > 2 mm, 40,7% > 3 mm y el 16% > 4 mm. Ninguna variable se asoció con mayor desviación, con el número de trayectos realizado ni con diferencias en mejoría del UPDRS III. Sólo un paciente presentó hemorragia.
Conclusiones: El uso del MR permitió una corrección significativa del blanco en un amplio porcentaje de casos, la cual podría relacionarse con un mejor resultado clínico. No se asociaron factores al grado de desviación, la frecuencia de complicaciones serias es baja.

Métricas

Cargando métricas ...

Citas

Castrioto A, Lozano AM, Poon YY, et al. Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation: Arch Neurol. 2011 Dec;68(12):1550-6.

Weaver FM, Follett KA, Stern M, et al. Randomized trial of deep brain stimulation for Parkinson disease: Thirty-six-month outcomes: Neurology. 2012 Jul 3;79(1):55-65.

Williams A, Gill S, Varma T, et al. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson’s disease (PD SURG trial): a randomised, open-label trial: Lancet Neurol. 2010 Jun;9(6):581-91.

Bronstein JM, Tagliati M, Alterman RL, et al. Deep brain stimulation for Parkinson disease: an expert consensus and re- view of key issues. Arch Neurol. 2011 Feb;68(2):165.

Rezai AR, Kopell BH, Gross RE, et al. Deep brain stimula- tion for Parkinson’s disease: surgical issues. Mov Disord. 2006 Jun;21 Suppl 14:S197-218.

Temel Y, Wilbrink P, Duits A, et al. Single electrode and mul- tiple electrode guided electrical stimulation of the subthalamic nucleus inadvanced Parkinson’s disease: Neurosurgery. 2007 Nov;61(5 Suppl 2):346-55.

Machado A, Rezai AR, Kopell BH, et al. Deep brain stimulation for Parkinson’s disease: surgical technique and perioperative management. Mov Disord. 2006 Jun;21 Suppl 14:S247-58.

Lanotte MM, Rizzone M, Bergamasco B, et al. Deep brain stimula- tion of the subthalamic nucleus anatomical, neurophysiological, and outcome correlations with the effects of stimulation: J Neurol Neurosurg Psychiatry. 2002 Jan;72(1):53-8.

Goodman RR, Kim B, McClelland S 3rd, et al. Operative techniques and morbidity with subthalamic nucleus deep brain stimulation in 100 consecutive patients with advanced Parkinson’s disease: J Neurol Neurosurg Psychiatry. 2006 Jan;77(1):12-7.

Sumanaweera TS, Adler JR Jr, Napel S, Glover GH. Charac- terization of Spatial Distortion in Magnetic Resonance Imaging and Its Implications for Stereotactic Surgery: Neurosurgery. 1994 Oct;35(4):696-703.

Elias WJ, Fu KM, Frysinger RC. Cortical and subcortical brain shift during stereotactic procedures: J Neurosurg. 2007 Nov;107(5):983-8.

Maciunas RJ, Galloway RL Jr, Latimer JW. The application accu- racy of stereotactic frames.Neurosurgery. 1994 Oct;35(4):682-94.

Burchiel KJ, Nguyen TT, Coombs BD, Szumoski J. MRI distortion and stereotactic neurosurgery using the Cosman-Roberts-Wells and Leksell frames. Stereotact Funct Neurosurg. 1996;66(1- 3):123-36.

Sterio D, Zonenshayn M, Mogilner AY, et al. Neurophysiologi- cal refinement of subthalamic nucleus targeting. Neurosurgery. 2002 Jan;50(1):58-67

Zhu XL, Hamel W, Schrader B, et al. Magnetic Resonance Imaging-Based Morphometry and Landmark Correlation of Basal Ganglia Nuclei. Acta Neurochir (Wien). 2002 Oct;144(10):959-69.

Daniluk S, G Davies K, Ellias SA, et al. Assessment of the vari- ability in the anatomical position and size of the subthalamic nucleus among patients with advanced Parkinson’s disease using magnetic resonance imaging. Acta Neurochir (Wien). 2010 Feb;152(2):201-10.

Paek SH, Yun JY, Song SW, et al. The clinical impact of precise electrode positioning in STN DBS on three-year outcomes. J Neurol Sci. 2013 Apr 15;327(1-2):25-31.

Paek SH, Lee JY, Kim HJ, et al. Electrode position and the clinical outcome after bilateral subthalamic nucleus stimulation. J Korean Med Sci. 2011 Oct;26(10):1344-55.

Zonenshayn M, Rezai AR, Mogilner AY, et al. Comparison of ana- tomic and neurophysiological methods for subthalamic nucleus targeting. Neurosurgery 2000 47:282–294.

Sugita K, Takaoka Y, Mutsuga N, et al. Correlation between ana- tomically calculated target point and physiologically determined point in stereotaxic surgery. Confin Neurol 1972;34:84-93.

Molinuevo JL, Valldeoriola F, Valls-Solé J. Usefulness of neu- rophysiologic techniques in stereotactic subthalamic nucleus stimulation for advanced Parkinson’s disease: Clin Neurophysiol. 2003 Oct;114(10):1793-9.

Foster A, Eljamel MS, Varma TR, et al. Audit of neurophysiological recording during movement disorder surgery. Stereotact Funct Neurosurg. 1999;72(2-4):154-6.

Palur RS, Berk C, Schulzer M, Honey CR: A metaanalysis com- paring the results of pallidotomy performed using microelectrode recording or macroelectrode stimulation. J Neurosurg 2002 96:1058–1062.

Karaka P, Koç Z, Koç F, Gülhal Bozkır M. Morphometric MRI evaluation of corpus callosum and ventricles in normal adults. Neurol Res. 2011 Dec;33(10):1044-9.

Senatus PB, Teeple D, McClelland S 3rd, et al. A technique for minimally altering anatomically based subthalamic electrode targeting by microelectrode recording. Neurosurg Focus. 2006 May 15;20(5):E8.

Guridi J, Rodríguez-Oroz MC, Lozano AM, et al. Targeting the basal ganglia for deep brain stimulation in Parkinson’s disease. Neurology 2000 55[Suppl 6]:S21–S28.

Guridi J, Rodríguez-Oroz MC, Ramos E, et al. Discrepancy be- tween imaging and neurophysiology in deep brain stimulation of medial pallidum and subthalamic nucleus in Parkinson’s disease [in Spanish]. Neurologia 2002 17:183–192.

Bubnov AN. Individual anatomic variability of the subthalamic nu- cleus in frontal sections. Arkh Anat Gistol Embriol. 1975;68(2):85- 87.

Patil PG, Conrad EC, Aldridge JW, et al. The anatomical and elec- trophysiological subthalamic nucleus visualized by 3-T magnetic resonance imaging. Neurosurgery. 2012 Dec;71(6):1089-95.

Romanelli P, Heit G, Hill BC, et al. Microelectrode record- ing revealing a somatotopic body map in the subthalamic nucleus in humans with Parkinson disease. Neurosurg. 2004 Apr;100(4):611-8.

Theodosopoulos PV, Marks WJ Jr, Christine C, Starr PA. Locations of movement-related cells in the human subthalamic nucleus in Parkinson’s disease. Mov Disord. 2003 Jul;18(7):791-8.

Rodriguez-Oroz MC, Rodriguez M, Guridi J, Mewes K, et al. The subthalamic nucleus in Parkinson’s disease: somatotopic organi- zation and physiological characteristics. Brain. 2001 Sep;124(Pt 9):1777-90.

Kleiner-Fisman G, Herzog J, Fisman DN, et al. Subthalamic nucleus deep brain stimulation summary and meta-analysis of outcomes. Mov Disord. 2006 Jun;21 Suppl 14:S290-304.

Deuschl G, Schade-Brittinger C, Krack P, et al. A random- ized trial of deep-brain stimulation for Parkinson’s disease. N Engl J Med. 2006 Aug 31;355(9):896-908.

Schüpbach WM, Maltête D, Houeto JL, et al. Neurosurgery at an earlier stage of Parkinson disease: A randomized, controlled trial. Neurology. 2007 Jan 23;68(4):267-71.

Schuepbach WM, Rau J, Knudsen K, et al. Neurostimulation for Parkinson’s Disease with Early Motor Complications. N Engl J Med. 2013 Feb 14;368(7):610-22.

Weaver FM, Follett K, Stern M et al. Bilateral deep brain stimu- lation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA. 2009 Jan 7;301(1):63-73.

Honey CR, Berk C, Palur RS, Schulzer M. Microelectrode recording for pallidotomy: mandatory, beneficial or dangerous? Stereotact Funct Neurosurg. 2001 77:98–100.

Alkhani A, Lozano AM. Pallidotomy for Parkinson disease: a review of contemporary literature. J Neurosurg 2001 94:43–49.

Zrinzo L, Foltynie T, Limousin P, Hariz MI: Reducing hemorrhagic complications in functional neurosurgery: a large case series and systematic literature review. J Neurosurg. 2012 Jan;116(1):84-94.

Sansur CA, Frysinger RC, Pouratian N, et al. Incidence of symp- tomatic hemorrhage after stereotactic electrode placement. J Neurosurg. 2007 Nov;107(5):998-1003.

Binder DK, Rau GM, Starr PA. Risk factors for hemorrhage dur- ing microelectrode-guided deep brain stimulator implantation for movement disorders. Neurosurgery. 2005 56:722–732.

Goodman RR, Kim B, McClelland S 3rd, et al. Operative techniques and morbidity with subthalamic nucleus deep brain stimulation in 100 consecutive patients with advanced Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2006 Jan;77(1):12-7.

Vergani F, Landi A, Pirillo D, et al. Surgical, Medical, and Hard- ware Adverse Events in a Series of 141 Patients Undergoing Subthalamic Deep Brain Stimulation for Parkinson Disease. World Neurosurg. 2010 Apr;73(4):338-44.

Hu X, Jiang X, Zhou X et al. Avoidance and management of surgi- cal and hardware-related complications of deep brain stimulation. Stereotact Funct Neurosurg. 2010;88(5):296-303.

Chou YC, Lin SZ, Hsieh WA, et al. Surgical and hardware com- plications in subthalamic nucleus deep brain stimulation: J Clin Neurosci. 2007 Jul;14(7):643-9.

Guehl D, Cuny E, Benazzouz A, et al. Side-effects of subthalamic stimulation in Parkinson’s disease: clinical evolution and predictive factors. Eur J Neurol. 2006 Sep;13(9):963-71.

Descargas

Publicado

2015-12-01

Cómo citar

1.
Bastidas Benavides JL, Serrano Ortiz JM, Rueda Acevedo M, Bareño Silva J. Experiencia en el uso de microrregistro para estimulación cerebral profunda del núcleo subtalámico en pacientes con enfermedad de Parkinson. NeuroTarget [Internet]. 1 de diciembre de 2015 [citado 22 de octubre de 2024];9(4):18-24. Disponible en: https://neurotarget.com/index.php/nt/article/view/210

Número

Sección

Original